FILTRICINE Trademark

Trademark Overview

On Tuesday, November 27, 2018, a trademark application was filed for FILTRICINE with the United States Patent and Trademark Office. The USPTO has given the FILTRICINE trademark a serial number of 88207811. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 13, 2023. This trademark is owned by Filtricine, Inc.. The FILTRICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of technology in the field of dietary and nutritional supplement; dietary and nutritional supplement research and development; research and development of new in dietary and nutritional supplement products for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; research and development of new dietary and nutritional supplement products for use in the field of dialysis; medical and scientific research in the field of dietary and nutritional supplement in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medi...
filtricine

General Information

Serial Number88207811
Word MarkFILTRICINE
Filing DateTuesday, November 27, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesResearch and development of technology in the field of dietary and nutritional supplement; dietary and nutritional supplement research and development; research and development of new in dietary and nutritional supplement products for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; research and development of new dietary and nutritional supplement products for use in the field of dialysis; medical and scientific research in the field of dietary and nutritional supplement in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutritional supplement research, namely, medical and scientific research relating to remediating nutrient deprivation for use in connection with a wide variety of therapeutic areas

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 15, 2018
Primary Code042
First Use Anywhere DateWednesday, May 1, 2019
First Use In Commerce DateWednesday, May 1, 2019

Trademark Owner History

Party NameFiltricine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
Party NameFiltricine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, June 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, June 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 7, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 7, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, November 4, 2022USE AMENDMENT FILED
Friday, November 4, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 5 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 5 FILED
Monday, April 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU EXTENSION 4 GRANTED
Friday, October 15, 2021SOU EXTENSION 4 FILED
Friday, October 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021SOU EXTENSION 3 GRANTED
Friday, April 23, 2021SOU EXTENSION 3 FILED
Friday, April 23, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 14, 2020SOU EXTENSION 2 GRANTED
Wednesday, October 14, 2020SOU EXTENSION 2 FILED
Wednesday, October 14, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 4, 2020SOU EXTENSION 1 GRANTED
Monday, May 4, 2020SOU EXTENSION 1 FILED
Monday, May 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, August 6, 2019ASSIGNED TO LIE
Tuesday, August 6, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 6, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, August 6, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, February 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 14, 2019NON-FINAL ACTION E-MAILED
Thursday, February 14, 2019NON-FINAL ACTION WRITTEN
Thursday, February 14, 2019ASSIGNED TO EXAMINER
Saturday, December 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 30, 2018NEW APPLICATION ENTERED

Related Keywords

filtricine research dietary nutritional supplement field development including medical scientific oncology